ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia

The molecular etiology of human progenitor reprogramming into self-renewing leukemia stem cells (LSC) has remained elusive. Although DNA sequencing has uncovered spliceosome gene mutations that promote alternative splicing and portend leukemic transformation, isoform diversity also may be generated by RNA editing mediated by adenosine deaminase acting on RNA (ADAR) enzymes that regulate stem cell maintenance. In this study, whole-transcriptome sequencing of normal, chronic phase, and serially transplantable blast crisis chronic myeloid leukemia (CML) progenitors revealed increased IFN-γ pathway gene expression in concert with BCR-ABL amplification, enhanced expression of the IFN-responsive ADAR1 p150 isoform, and a propensity for increased adenosine-to-inosine RNA editing during CML progression. Lentiviral overexpression experiments demonstrate that ADAR1 p150 promotes expression of the myeloid transcription factor PU.1 and induces malignant reprogramming of myeloid progenitors. Moreover, enforced ADAR1 p150 expression was associated with production of a misspliced form of GSK3β implicated in LSC self-renewal. Finally, functional serial transplantation and shRNA studies demonstrate that ADAR1 knockdown impaired in vivo self-renewal capacity of blast crisis CML progenitors. Together these data provide a compelling rationale for developing ADAR1-based LSC detection and eradication strategies.

[1]  Jin Billy Li,et al.  Accurate identification of human Alu and non-Alu RNA editing sites , 2012, Nature Methods.

[2]  Leo D. Wang,et al.  Dynamic niches in the origination and differentiation of haematopoietic stem cells , 2011, Nature Reviews Molecular Cell Biology.

[3]  I. Weissman,et al.  The aging of hematopoietic stem cells , 1996, Nature Medicine.

[4]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[5]  R. Sorek,et al.  Is abundant A-to-I RNA editing primate-specific? , 2004, Trends in genetics : TIG.

[6]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[7]  D. Perrotti,et al.  From mRNA Metabolism to Cancer Therapy: Chronic Myelogenous Leukemia Shows the Way , 2007, Clinical Cancer Research.

[8]  C. Jamieson.  The MLLgnant consequences of reverting to an embryonic transcriptional program. , 2009, Cell stem cell.

[9]  K. Nishikura,et al.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. , 2000, RNA.

[10]  M. O’Connell,et al.  Down-regulation of RNA Editing in Pediatric Astrocytomas , 2008, Journal of Biological Chemistry.

[11]  Wenwei Zhang,et al.  Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome , 2012, Nature Biotechnology.

[12]  G. Zheng,et al.  [Expression of ADAR1 isoforms in murine acute T-ALL leukemia model]. , 2011, Zhongguo shi yan xue ye xue za zhi.

[13]  Brenda L. Bass,et al.  An unwinding activity that covalently modifies its double-stranded RNA substrate , 1988, Cell.

[14]  S. Orkin,et al.  ADAR1 is essential for maintenance of hematopoiesis and suppression of interferon signaling , 2008, Nature Immunology.

[15]  Angelo J. Canty,et al.  Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.

[16]  T. Holyoake,et al.  Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells. , 2007, Blood.

[17]  P. Seeburg,et al.  Modulation of microRNA processing and expression through RNA editing by ADAR deaminases , 2006, Nature Structural &Molecular Biology.

[18]  W. Vainchenker,et al.  Miscreant myeloproliferative disorder stem cells , 2008, Leukemia.

[19]  T. Matise,et al.  Widespread RNA editing of embedded alu elements in the human transcriptome. , 2004, Genome research.

[20]  M. O’Connell,et al.  Editing independent effects of ADARs on the miRNA/siRNA pathways , 2009, The EMBO journal.

[21]  M. Copland,et al.  Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. , 2006, Blood.

[22]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[23]  Debashis Sahoo,et al.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age , 2011, Proceedings of the National Academy of Sciences.

[24]  J. Nickerson,et al.  Induction of protein translation by ADAR1 within living cell nuclei is not dependent on RNA editing. , 2002, Molecular cell.

[25]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[26]  Chad A Shaw,et al.  Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation , 2007, PLoS biology.

[27]  Susan Branford,et al.  Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. , 2003, The New England journal of medicine.

[28]  K. Nishikura,et al.  Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. , 2000, Science.

[29]  G. Daley,et al.  The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. , 1986, Science.

[30]  Pavel V. Baranov,et al.  DARNED: a DAtabase of RNa EDiting in humans , 2010, Bioinform..

[31]  Andreas Trumpp,et al.  IFNα activates dormant haematopoietic stem cells in vivo , 2009, Nature.

[32]  Mayetri Gupta,et al.  The RNA Editor Gene ADAR1 is Induced in Myoblasts by Inflammatory Ligands and Buffers Stress Response , 2010, Clinical and translational science.

[33]  I. Mian,et al.  A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Tongde Wu,et al.  Involvement of PU.1 in mouse adar-1 gene transcription induced by high-dose esiRNA. , 2009, International journal of biological macromolecules.

[35]  Qingde Wang,et al.  RNA editing catalyzed by ADAR1 and its function in mammalian cells , 2011, Biochemistry (Moscow).

[36]  Zipora Y. Fligelman,et al.  Systematic identification of abundant A-to-I editing sites in the human transcriptome , 2004, Nature Biotechnology.

[37]  T. Cheng,et al.  ADAR1 is required for hematopoietic progenitor cell survival via RNA editing , 2009, Proceedings of the National Academy of Sciences.

[38]  Alexander Rich,et al.  Widespread A-to-I RNA Editing of Alu-Containing mRNAs in the Human Transcriptome , 2004, PLoS biology.

[39]  M. O’Connell,et al.  ADARs have effects beyond RNA editing , 2009, Cell cycle.

[40]  Y. Nie,et al.  Widespread inosine‐containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation , 2003, Immunology.

[41]  T. Skorski,et al.  Chronic myeloid leukemia: mechanisms of blastic transformation. , 2010, The Journal of clinical investigation.

[42]  Jae-Hyung Lee,et al.  Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. , 2012, Genome research.

[43]  I. Weissman,et al.  Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation , 2009, Proceedings of the National Academy of Sciences.

[44]  Eli Eisenberg,et al.  RNA-editing-mediated exon evolution , 2007, Genome Biology.

[45]  T. Dawson,et al.  Regulation of alternative splicing by RNA editing , 1999, Nature.

[46]  Angela Gallo,et al.  A-to-I RNA editing: the "ADAR" side of human cancer. , 2012, Seminars in cell & developmental biology.

[47]  G. Zheng,et al.  Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemias. , 2011, Biochemical and biophysical research communications.

[48]  K. Nishikura,et al.  Editor meets silencer: crosstalk between RNA editing and RNA interference , 2006, Nature Reviews Molecular Cell Biology.

[49]  J. Itskovitz‐Eldor,et al.  Alu Sequences in Undifferentiated Human Embryonic Stem Cells Display High Levels of A-to-I RNA Editing , 2010, PloS one.

[50]  H. Kantarjian,et al.  Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy , 2012, Cancer.